Silence Therapeutics reported 0 in Loan Capital for its fiscal quarter ending in September of 2024.


Loan Capital Change Date
AstraZeneca USD 25.99B 1.9B Jun/2025
Autolus Therapeutics Ltd 244.63M 8.81M Jun/2025
Hikma Pharmaceutical USD 607M 454M Dec/2024
Novartis USD 24.06B 2.4B Jun/2025
Roche Holding CHF 32.1B 1.94B Dec/2024
Silence Therapeutics 0 0 Sep/2024